Furthermore, statistical correlations were found between mRNA expression of the different NFI family members and survival outcomes in head and neck, liver, kidney, cervical, esophageal and pancreatic cancers, as well as sarcoma. This evidence concerns the gene NFIC and familial pancreatic carcinoma.